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Abstract
 
Recent data indicate that some cytotoxic T cells (CTLs) recognize so-called cryptic epitopes,
encoded by nonprimary open reading frame (ORF) sequences or other nonclassical expression
pathways. We describe here a novel mechanism leading to generation of a cryptic CTL
epitope. We isolated from the synovial fluid of a patient suffering from a Reiter’s syndrome an
autoreactive T cell clone that recognized cellular IL-10 in the HLA-B
 
*
 
2705 context. The min-
imal IL-10 sequence corresponding to nucleotides 379–408 was shown to activate this clone,
upon cotransfection into COS cells with the DNA encoding HLA-B
 
*
 
2705, but the synthetic
peptide deduced from this sequence did not stimulate the clone. Using a site-directed mu-
tagenesis approach, we found that this clone recognized a transframe epitope generated by an
internal 
 
 
 
1 frameshifting in the IL-10 sequence and so derived partly from ORF1, partly from
ORF2. We defined that 
 
 
 
1 frameshifting was induced by a specific heptamer sequence. These
observations illustrate the variety of mechanisms leading to generation of cryptic epitopes and
suggest that frameshifting in normal cellular genes may be more common than expected.
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Introduction
 
It has been generally assumed that degradation of full-
length protein supplies the majority of epitopes presented
by MHC molecules to the T cell antigen receptors. Yet,
recent data indicate that some CTL epitopes in viral, tu-
mor, and model systems are generated through nontradi-
tional pathways of gene expression, when unexpected
events take place during transcription, splicing or transla-
tion (for a review, see reference 1). Examples include pep-
tides encoded by cryptic translational reading frames, in
some cases even without upstream AUG initiation codons
(2–6), derived from reverse strand transcription (7) or from
improper splicing of introns (8).
Here we describe a new mechanism leading to generation
of a class I CTL epitope. In the course of an extensive analy-
sis of CD8 T cell responses to Epstein-Barr virus (EBV)
within synovial fluid-derived T cells from patients suffering
from chronic arthritis (9, 10), we observed a response to
BCRF1, the EBV-encoded IL-10, in the HLA-B27 context
(10). On account of the strong homology between BCRF1
and human IL-10 (11), we presently searched for possible
cross-reactive T cell responses against IL-10 in these pa-
tients. This led to the isolation of an autoreactive CD8 T
cell clone that recognized a cryptic epitope derived from
cellular IL-10, in the HLA-B
 
*
 
2705 context. We show here
that this transframe epitope, derived partly from ORF1
partly from ORF2, resulted from an internal 
 
 
 
1 frame-
shifting in the IL-10 sequence.
 
Materials and Methods
 
T Cells.
 
The CD8 synovial T cell line from patient RS2 was
expanded in vitro, under polyclonal activation conditions and
clones were obtained by seeding synovial T cells at 0.3 cells per
well as described previously (9).
 
Expression Vectors and Production of Modified cDNAs.
 
Genomic
 
HLA-B
 
*
 
2705
 
 was cloned into pcDNA3 (Invitrogen). cDNA en-
coding full-length or truncated BCRF1 or human IL-10 was cloned
into pCI-neo (Promega). Truncated IL-10 or BCRF1 cDNAs, gen-
erated by PCR amplification, were cloned into pCI-neo. A pFlag
expression vector was constructed to allow the expression of
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shorter constructs by inserting the sequence encoding the tag Flag
in the pCI-neo expression vector. The Flag sequence contains, at
the 5
 
 
 
 end, a favorable Kozak sequence for translation initiation
and a methionine start codon. A pFlag-IL-10 
 
 
 
4 and a pFlag-
BCRF1 
 
 
 
4 vectors were also constructed. IL-10 and BCRF1
site-directed mutants were generated by introducing the desired
point mutation in oligonucleotide primers in the IL-10 
 
 
 
4 and
BCRF1 
 
 
 
4 sequences, respectively. All constructs were checked
by sequencing.
 
Transfections and T Cell Stimulation Assays.
 
Transfection into
COS cells was performed by the DEAE-dextran chloroquine
method as described previously (9). Transfectants were tested af-
ter 48 h for their ability to stimulate TNF-
 
 
 
 production by T
cells. 5 
 
 
 
 10
 
3
 
 cells from a given T cell clone were added to trans-
fected COS cells, culture supernatants were harvested 6 h later
and tested for TNF content by measuring culture supernatant cy-
totoxicity to WEHI 164 clone 13 in a colorimetric assay (9).
C1R cells were stably transfected with HLA-B
 
*
 
2705 genomic
DNA and IL-10 or BCRF1 cDNA, using neomycin and zeocin
as selection markers.
 
Peptide Stimulation Assays.
 
Characterization of the IL-10/
B27 epitope was achieved by assaying the ability of various pep-
tides (Genosys) loaded at various nanomolar concentrations on
HLA-B
 
*
 
2705 BLCL (i) to induce lysis of these BLCL by T cell
clone 35 as described previously (9) and (ii) to trigger TNF-
 
 
 
 re-
lease by clone 35 T cells. 3 
 
 
 
 10
 
4
 
 T cells were incubated for 6 h
with 3 
 
 
 
 10
 
3
 
 EBV-B cells loaded with peptides at various con-
centrations, and the amount of TNF-
 
 
 
 released in the superna-
tant was estimated.
 
Reporter Luciferase Assays.
 
Frameshift reporter plasmids were
generated by inserting primers containing the IL-10 sequence
(CTTCCCT) or a random irrelevant sequence (GATTCTT) in
the 
 
Firefly
 
 luciferase gene in 
 
 
 
1 frame (pIL10-
 
FF
 
 and pRandom-
 
FF
 
) and in the 
 
Renilla
 
 luciferase gene in 0 frame (pIL10-
 
RL
 
 and
pRandom-
 
RL
 
). These constructs were cloned into pCI-neo vec-
tor and critical regions were checked by sequencing. 100 ng of a
 
Firefly
 
 luciferase plasmid together with 100 ng of the correspond-
ing 
 
Renilla
 
 luciferase control were cotransfected into COS cells.
Luciferase activities of the cell lysates were determined 48 h after
the transfection by using the Dual Luciferase Assay System
(Promega) and a Berthold Junior luminometer (PerkinElmer In-
struments). pGL3-Control (
 
Firefly
 
) and pRL-SV40 (
 
Renilla
 
) vec-
tors (Promega) were used to control transfection efficiency.
 
Results
 
Isolation of an Autoreactive CD8 T Cell Clone Recognizing
Human IL-10 in the HLA-B
 
*
 
2705 Context.
 
In the course
of an analysis of CD8 T cell responses to EBV within syn-
ovial fluid-derived T cell lines from patients suffering from
chronic arthritis, we showed that the CD8 synovial T cell
line from a patient with a Reiter’s syndrome (patient RS2),
recognized COS cells cotransfected with DNAs coding for
HLA-B
 
*
 
2705 and BCRF1 (10). Owing to the high ho-
mology between BCRF1 and human IL-10 (85% homol-
ogy if the leader sequence is excluded), we looked for
possible cross-reactive T cell responses against BCRF1 and
IL-10. To this end, 80 clones derived from the CD8 synovial
T cell line from patient RS2 were screened for recognition
of COS cells transfected with HLA-B
 
*
 
2705 DNA and with
BCRF1 or IL-10 cDNA. One clone (#35), produced
TNF-
 
 
 
 when incubated with COS cells cotransfected with
IL-10 cDNA and the DNA coding for HLA-B
 
*
 
2705 (Fig.
1 B). By contrast, this clone did not recognize COS cells
expressing HLA-B27 or IL-10 alone, or BCRF1/B27 (Fig.
1 and 2). Similarly, significant cytolytic activity (Fig. 2) and
TNF release (data not shown) by clone 35 were both acti-
vated after a short-term coculture with C1R B cells stably
transfected with expression vectors coding for IL-10 and
HLA-B
 
*
 
2705.
To identify the minimal IL-10 epitope recognized by
clone 35, several truncated IL-10 variants (
 
 
 
1, 
 
 
 
2, and 
 
 
 
3)
were transfected into COS cells along with the HLA-
B
 
*
 
2705 DNA. Reactivity of the T cell clone 35 to the
transfected COS cells was measured in a TNF release assay
(Fig. 1). As IL-10 
 
 
 
1 (1–414), but not IL-10 
 
 
 
2 (1–375),
sequence stimulated T cell clone activation, we generated
Figure 1. Mapping of the IL-10 cDNA sequence encoding the antigenic
peptide recognized by clone 35. (A) Schematic representation of IL-10 and
BCRF1 sequences. The IL-10 full-length and truncated cDNAs are
marked in black. The IL-10  3 and  4 PCR products were cloned into a
Flag-pCI-neo vector. The BCRF1 cDNA sequence is represented by
cross-hatched boxes. The Flag sequence is represented by open boxes.
Nucleotides are numbered from the start codon. (B) The various con-
structions shown in A were tested for their ability to induce clone 35
TNF production after transfection into COS cells along with a plasmid
construct encoding HLA-B*2705. Constructions with IL-10 sequences,
in which the thymine at position 394 was deleted (FS 394), were also in-
cluded in the assay. 
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the small IL-10 
 
 
 
3 fragment (355–414), containing an in-
ternal ATG start codon, which induced clone 35 activa-
tion, though suboptimally. To increase T cell clone 35 ac-
tivation, we added a Flag tag in front of the shortest
constructs. The 
 
 
 
3 construct was cloned into a pCI-neo
Flag expression vector, thus expressed as a Flag-IL-10 
 
 
 
3
fusion protein, and optimal response of clone 35 was then
obtained. A minimal Flag-IL-10 
 
 
 
4 construction (379–
408), coding for 10 amino acids, was also capable to induce
clone 35 activation (Fig. 1) and was used for further analy-
sis. In contrast, neither the BCRF1 full-length cDNA nor
the pFlag-BCRF1 
 
 
 
4 (358–387), homologous to the IL-10
 
 
 
4 stimulatory sequence, activated clone 35. This was
rather unexpected because the amino acid sequence of the
IL-10 stimulatory region was 100% homologous to the
corresponding sequence in BCRF1 (Fig. 3 A).
 
Clone 35 Recognizes a Cryptic Epitope Generated by an
Internal 
 
 
 
1 Frameshifting in the IL-10 Sequence.
 
The non-
amer peptide deduced from the minimal IL-10 
 
 
 
4 se-
quence, HRFLPCENK, and three related peptides
(HRFLPCENKS, HRFLPCENKSK, CHRLPCENKSK),
were screened for their ability to sensitize HLA-B
 
*
 
2705
 
 
 
EBV-B cells to lysis by clone 35 and to stimulate TNF re-
lease by clone 35 after loading on HLA-B27
 
 
 
 EBV-B cells,
but none of them were stimulatory (Fig. 4, and data not
shown). As the nucleotidic sequence greatly differed be-
tween the BCRF1 and the IL-10 genes (Fig. 3 A), the first
possibility we explored was the recognition of an epitope
resulting from an alternative ORF. One peptide (IDFF-
PVKTRA), deduced from IL-10 ORF2, was synthesized
but it failed to activate clone 35 in TNF or cytotoxicity as-
says (not shown). ORF3-derived peptides were not tested
owing to the presence of a stop codon (Fig. 3 A). We then
explored the possibility that the epitope recognized by
clone 35 was posttranslationally modified before presenta-
tion by generating IL-10 site-directed mutants. We could
thus exclude the recognition of an epitope modified by
 
N
 
- or 
 
O
 
-glycosylation (data not shown).
Of the large number of constructions cloned into the
pFlag-IL-10 
 
 
 
4 expression vector, one was fortuitously
generated, in which the thymine at position 394 was miss-
ing (IL-10 
 
 
 
4 FS-394). This mutation, which originated
from a contaminant in the primer preparation used for
PCR, resulted in an internal 
 
 
 
1 frameshift (FS), and con-
sequently yielded a peptide encoded partly by ORF1 partly
by ORF2 (Fig. 3 B). Surprisingly, this construction
strongly induced TNF release by clone 35 in a COS trans-
fection assay (Fig. 1 B). The synthetic nonamer peptide de-
duced from this sequence (HRFLPVKTR), when loaded
on HLA-B2705
 
 
 
 EBV-B cells, clearly activated clone 35 as
shown by lytic activity and TNF release (Fig. 4). Half-max-
imal lysis by the CTL clone was obtained at 
 
 
 
10 nM con-
centration. The deletion of nucleotide 394 in the full
length IL-10 cDNA (IL-10 FS-394) also led to clone 35
activation (Fig. 1 B).
Figure 2. Cytotoxicity of clone 35 to C1R EBV-B cells coexpressing
IL-10 and HLA-B*2705. Clone 35 killed C1R cells cotransfected with
DNA encoding HLA-B*2705 and IL-10, but did not kill C1R cells
transfected with the DNA encoding HLA-B*2705 alone nor C1R
cotransfected with plasmids encoding BCRF1 and B*2705. Clone RS2
c21.2, recognizing BCRF1 in the HLA-B*2705 context (reference 10),
killed C1R cotransfected with plasmids encoding BCRF1 and B*2705
but did not kill C1R B*2705 cells nor C1R IL-10 cells. Results are ex-
pressed as the percentage of specific lysis at an E/T ratio of 10:1. Error
bars indicate SD.
Figure 3. Stimulation of clone 35 by IL-10 or BCRF1 nucleotidic se-
quences. The predictive amino acid sequences are indicated. Various IL-10
or BCRF1 constrictions were transfected into COS cells together with
HLA-B*2705 DCNA and tested for their ability to stimulate TNF release
by clone 35. (A) Nonmutated IL-10 or BCRF1 sequences. (B)  1 frame-
shift sequences. (C) Mutated IL-10 or BCRF1 sequences. Substituted nu-
cleotides are shown in bold type and are underlined. Nucleotides are
numbered from the start codon. WT, wild-type sequences for IL-10  4
and BCRF1  4. 
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Definition of the Frameshift Site in the IL-10 Sequence.
 
To
determine if a precise nucleotidic sequence favored frame-
shifting, we first synthesized a set of peptides whose sequence
was deduced from systematic 
 
 
 
1 frameshifting in the rele-
vant IL-10 nucleotidic sequence (nucleotides 379–408). It
appeared that all the 
 
 
 
1 frameshifts between positions 389–
395, which yielded two distinct peptides, HRFLPVKTR
(frameshift at positions 389–394) and HRFLPLKTR
(frameshift at position 395), were able to optimally induce
clone 35 activation, as shown by both TNF release and cy-
totoxicity assays (Fig. 4). This targeted the sequence 389 to
395 as the likely frameshift site.
We generated various BCRF1/IL-10 chimeric con-
structs to try either to induce recognition of BCRF1 or to
abrogate IL-10 recognition (Fig. 3 C). The results obtained
supported a key role of the CCC triplet in IL-10 sequence
in frameshift induction. In fact, silent mutation of codon
CCC to CCG in the IL-10 sequence abrogated activation
of clone 35 (Fig. 3 C). We also succeeded in modifying the
corresponding BCRF1 sequence such as to induce activa-
tion of clone 35, thus confirming that the CCC codon was
critical. Although the wild-type BCRF1 nucleotidic se-
quence did not lead to clone 35 activation in COS assay,
the BCRF1 sequence in which the thymine at position 373
was deleted activated clone 35. However, the peptide de-
duced from this BCRF1 frameshifted sequence (HR-
FLPVRTR) was less efficient to activate clone 35 than the
IL-10 transframe peptide (HRFLPVKTR) (Fig. 4), most
probably due to the arginine to lysine replacement at posi-
tion 7. The mutation of GAG to GAA in the BCRF1 se-
quence, which encoded a lysine instead of an arginine
through frameshifting, was not sufficient to induce clone
35 activation, nor was the mutation of CCG to CCC. By
contrast, introduction of both mutations resulted in weak
recognition of the BCRF1 construct by clone 35 (Fig. 3
C). Finally, when we mutated CTG to CTT, CCG to
CCC, and GAG to GAA, clone 35 was optimally activated
(Fig. 3 C). Taken together, these data indicate that the IL-
10 heptamer sequence CTT CCC T is the slippery site re-
sponsible for the 
 
 
 
1 frameshifting.
To test the ability of this sequence to induce a 
 
 
 
1
frameshift in COS cells, we generated a luciferase reporter
plasmid (pIL10–
 
FF
 
), in which the IL-10 heptamer slippery
site, followed by the sequence encoding 
 
Firefly
 
 luciferase,
was cloned into pCI-neo so that a 
 
 
 
1 frameshift was re-
quired for the luciferase to be translated. The heptameric
IL-10 sequence was also cloned upstream of the 
 
Renilla
 
 lu-
ciferase in 0 frame. After cotransfection into COS cells, lu-
ciferase activities were monitored and the efficiency of the
IL-10 sequence to induce 
 
 
 
1 frameshift was estimated by
the ratio 
 
Firefly
 
 activity/
 
Renilla
 
 activity. Luciferase activities
generated from cells harboring pRandom plasmids (with a
random heptamer) were monitored as a negative control to
determine the background level of nonprogrammed 
 
 
 
1
frameshifting. The results of these experiments demon-
strated a significant frameshifting induced by the IL-10 mo-
tif, when compared with the random plasmid (Fig. 5).
In an attempt to define at what step (i.e., DNA synthesis,
transcription or translation) the frameshift occurred, we se-
quenced a large number of cDNA clones (150) corre-
sponding to the minimal activating IL-10 sequence (nu-
cleotides 379–408). To this end, the pFlag-IL-10 
 
 
 
4
expression vector was transfected into COS cells (2 
 
 
 
 10
 
6
 
)
for 48 h. RT-PCR was performed from DNA-free RNA,
followed by automated sequencing. Sequence alignment
for the 150 cDNA clones showed that none of them had
deletion, mutation or insertion, thus suggesting that the
frameshift is probably occurring at the translational level.
 
Discussion
 
Several different forms of aberrant gene expression have
been shown to lead to the generation of a variety of MHC
class I–restricted epitopes (1–8). Here we describe the reac-
tivity of an HLA-B
 
*
 
2705-restricted CTL clone, isolated
from the synovial fluid of a patient suffering from a Reiter’s
syndrome, that recognized a transframe epitope generated
by a 
 
 1 frameshifting in IL-10 sequence. The  1 frame-
shift described here appears as a programmed frameshift
which occurred systematically in COS transfection assays.
This frameshift also occurred in EBV-B cells as indicated
by experiments using C1R B27/IL-10 transfectants. The
rather inefficient generation of transframe epitope in B cell
IL-10 transfectants, when compared with COS cells, could
possibly be due to downregulation of the transporter asso-
ciated with antigen processing (TAP) in these stable trans-
fectants, due to the high level of IL-10 (12), thus leading to
decreased presentation of antigens. The nonamer synthetic
peptide (HRFLPVKTR) deduced from the frameshifted
IL-10 sequence stimulated the CTL clone at nanomolar
range of concentration, indicating that this peptide is likely
to be the actual peptide. To our knowledge, this is the first
Figure 4. Identification of the antigenic peptide(s) recognized by the
synovial T cell clone 35. Various peptides were loaded at various concen-
trations on HLA-B*2705 BLCL and 3   104 T cells of clone 35 were
added to test their activation. The two peptides HRFLPVKTR and
HRFLPLKTR were deduced from  1 frameshift at various positions in
the minimal IL-10 sequence. The peptide HRFLPVRTR was deduced
from  1 FS in the BCRF1 sequence. The peptide deduced from IL-10
ORF1 (HRFLPCENKS) was used as a negative control. On the left scale
(black symbols) is shown the lysis by clone 35 of B27  target cells. Results
are expressed as percentage specific lysis at an E/T ratio of 10:1. On the
right scale (white symbols) is shown the TNF release.357 Saulquin et al. Brief Definitive Report
evidence that such a mechanism contributes to the genera-
tion of a T cell epitope.
The question arises of whether the frameshift is the result
of errors at the level of DNA replication, transcription or
translation. The slipping of DNA polymerase on the hep-
tameric slippery site during DNA synthesis seems unlikely
because if that occurred, the mutation would result in a
polymorphism in the IL-10 gene. Sequencing of a large
number of cDNA clones did not reveal any IL-10 mRNA
molecule missing one nucleotide, thus suggesting that the
frameshift could result from  1 ribosomal frameshift in in-
tact RNA molecules. Examples of programmed ribosomal
frameshifting have been described. Programmed –1 riboso-
mal frameshift signals are among the most extensively
characterized of these translational recoding phenomena.
Although most examples concern viral systems,  1 frame-
shifting has also been documented in bacteria (for a review,
see reference 13). To date, only one example of eukary-
otic mRNAs undergoing –1 frameshift has been reported
(14). However, using a bioinformatic approach, Hammell
et al. (15) could find that there are significant number of
consensus programmed –1 ribosomal frameshift signals
in the genome of all organisms for which large DNA da-
tabases exist. It has been shown that  1 frameshifting is
greatly enhanced by the presence of both a particular
heptamer sequence (slippery site), 5  of the frameshift site
upon which the ribosome shifts, and a sequence that forms
a defined RNA secondary structure, such as an RNA
pseudoknot, 3  of the shift site, which causes the ribosome
to pause over the slippery site (16). In the case of human
gene expression, only one family of genes, namely anti-
zyme, has been shown to undergo a  1 frameshifting for
which a pseudoknot downstream in the mRNA has a stim-
ulatory effect (17).
In the hypothesis that IL-10  1 frameshifting occurs
during translation, what could be the mechanism involved?
As the frameshift occurred in a minimal sequence, corre-
sponding to nucleotides 379–408, a pseudoknot is defini-
tively not involved. We found that a specific heptameric
sequence (CTT CCC T), which to our knowledge has not
been described as a slippery site previously, is central for
frameshift occurrence. We can hypothesize that this hep-
tameric sequence could induce a programmed translational
frameshift by either of two simple mechanisms which have
been described previously in the yeast (for a review, see
reference 18): (i) a true shift of the ribosome was described
for the yeast S. cerevisiae retrotransposon Ty1 element (19).
In that case, frameshifting is due to the ability of mRNA-
bound tRNA to slip between cognate or near-cognate
codons. In our model, the ribosome could shift when only
the P-site is occupied by the peptidyl tRNA (the anticodon
5  A/GAG 3  could base-pair to both the 0-frame CUU
and the  1 frame UUC codons. Translational slippage
could also occur with both P- and A-sites occupied by
tRNAs, the same peptidyl tRNAs would be present, and
the 5  GGG 3  anticodon of the aminoacyl-tRNA could
base pair equally well either the 0-frame CCC or  1 frame
CCU codon. (ii) A second mechanism, involving the mis-
insertion of the aminoacyl-tRNA into the  1 frame A-site
codon, rather a tRNA slippage, has been documented for
the yeast retrotransposon Ty3 (18, 20). In our model, it
would be possible that the prolyl-tRNA was mis-inserted
into the A-site in the wrong frame. Whatever the mecha-
nism involved, these results suggest that  1 ribosomal
frameshifting in normal cellular genes may be more com-
mon than expected.
The high level of expression of IL-10 in the rheumatoid
synovium (21) could contribute to the activation of au-
toreactive CTLs recognizing IL-10. Since a preliminary
analysis suggests recognition of this cryptic epitope of IL-
10 in another HLA-B27  patient, such a response could
have an important immunological impact and be of patho-
physiological relevance. T cells might become activated
and autoaggressive if the epitope is presented at high levels
on IL-10 producing cells and this could lead in vivo to
recognition and subsequent elimination of T cell regula-
Figure 5. Efficiency of the IL-10 heptamer sequence to induce  1
frameshifting. (A) Plasmids used to estimate  1 frameshifting induced by
the IL-10 sequence in a dual reporter luciferase assay. In pIL10-FF, the
IL-10 sequence CTTCCCT (boxed sequence), followed by the sequence
encoding the Firefly luciferase (bold) was cloned into pCI-neo vector. In
pRandom-FF, the IL-10 sequence was replaced by a random irrelevant
sequence. In these two constructs, to which was added a G (indicated by
an arrow), a  1 frameshift is required for the Firefly luciferase to be trans-
lated. In contrast, in pIL10-RL and in pRandom-RL, the reporter se-
quence of the Renilla luciferase is in 0 frame. (B) 100 ng of three plasmid
clones (#1, #2, and #3) corresponding to pIL10-FF or pRandom-FF
constructs were cotransfected into COS cells along with their control
plasmid encoding the Renilla luciferase in frame, respectively pIL10-RL
and pRandom-RL. A similar experiment was performed by mixing
equimolar quantities of each clone (Pool). 2 d later, Firefly and Renilla lu-
ciferases activities of the cell lysates were measured. Efficiency of the IL-10
or random sequence for  1 frameshift was estimated by the ratio Firefly
luciferase activity/Renilla luciferase activity.358 CTL Epitope Generated by Frameshifting
tory subsets known to produce high amounts of this cy-
tokine (22).
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